Literature DB >> 580732

Bile acid conjugation in the chimpanzee: effective sulfation of lithocholic acid.

M Schwenk, A F Hofmann, G L Carlson, J A Carter, F Coulston, H Greim.   

Abstract

To characterize the hepatic biotransformation in the chimpanzee of the primary bile acid chenodeoxycholic acid (chenic) and its major bacterial metabolite lithocholic acid (lithocholic) a mixture of trace amounts of 14C-lithocholic and 3H-chenic was injected intravenously into two animals with a bile fistula; the chemical form of radioactivity appearing in bile was inferred using thin layer chromatography. About 80% of chenic, and 70% of lithocholic was recovered in 90 min. Chenic was completely conjugated in bile, appearing predominantly as chenyltaurine (52%) and chenylglycine (37%). An unidentified conjugate (about 11%) was also found. Lithocholic was excreted completely as taurine and glycine conjugates, but the majority (63%) of conjugates was sulfated. Sulfation increased progressively with time, and lithocholylglycine was sulfated more than lithocholyltaurine. We conclude that the chimpanzee is similar to man in that the secondary bile acid lithocholic is efficiently sulfated. The chimpanzee thus differs from the baboon and rhesus monkey which sulfate lithocholic poorly. However, the chimpanzee differs from man and is similar to the baboon and rhesus monkey in showing preferential conjugation of bile acids with taurine. The results imply that hepatotoxicity caused by chenic, which is well documented in the rhesus monkey and baboon and has been related to defective lithocholic sulfation, should not occur in the chimpanzee.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 580732     DOI: 10.1007/bf01891965

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  37 in total

Review 1.  Detergent properties of bile salts: correlation with physiological function.

Authors:  A F Hofmann; D M Small
Journal:  Annu Rev Med       Date:  1967       Impact factor: 13.739

2.  An automatic zonal scraper and sample collector for radioassay of thin-layer chromatograms.

Authors:  F Snyder; H Kimble
Journal:  Anal Biochem       Date:  1965-06       Impact factor: 3.365

3.  Letter Prevention of chenodeoxycholic-acid toxicity with lincomycin.

Authors:  G Salen; H Dyrszka; T Chen; W H Saltzman; E H Mosbach
Journal:  Lancet       Date:  1975-05-10       Impact factor: 79.321

4.  Sulphated and unsulphated bile acids in serum, bile, and urine of patients with cholestasis.

Authors:  G P van Berge Henegouwen; K H Brandt; H Eyssen; G Parmentier
Journal:  Gut       Date:  1976-11       Impact factor: 23.059

5.  Lithocholate metabolism during chemotherapy for gallstone dissolution. 2. Absorption and sulphation.

Authors:  R N Allan; J L Thistle; A F Hofmann
Journal:  Gut       Date:  1976-06       Impact factor: 23.059

6.  Lithocholate metabolism during chenotherapy for gallstone dissolution. 1. Serum levels of sulphated and unsulphated lithocholates.

Authors:  R N Allan; J L Thistle; A F Hofmann; J A Carter; P Y Yu
Journal:  Gut       Date:  1976-06       Impact factor: 23.059

7.  The medical treatment of cholesterol gallstones: experience with chenodeoxycholic acid.

Authors:  L Barbara; E Roda; A Roda; C Sama; D Festi; G Mazzella; R Aldini
Journal:  Digestion       Date:  1976       Impact factor: 3.216

8.  Effect of oral chenodeoxycholic acid on bile acid kinetics and biliary lipid composition in women with cholelithiasis.

Authors:  R C Danzinger; A F Hofmann; J L Thistle; L J Schoenfield
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

9.  Controlled trial of chenodeoxycholic therapy for radiolucent gallstones. A multicenter study.

Authors:  A Gerolami; H Sarles; R Brette; A Paraf; J Rautureau; C Debray; C Bermann; J P Etienne; J C Chaput; J P Petite
Journal:  Digestion       Date:  1977       Impact factor: 3.216

10.  Metabolism of steroid and amino acid moieties of conjugated bile acids in man. 3. Cholyltaurine (taurocholic acid).

Authors:  G W Hepner; J A Sturman; A F Hofmann; P J Thomas
Journal:  J Clin Invest       Date:  1973-02       Impact factor: 14.808

View more
  5 in total

Review 1.  Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis. Part II.

Authors:  W H Bachrach; A F Hofmann
Journal:  Dig Dis Sci       Date:  1982-09       Impact factor: 3.199

2.  Altered bile acid metabolism in primary biliary cirrhosis.

Authors:  R Raedsch; B H Lauterburg; A F Hofmann
Journal:  Dig Dis Sci       Date:  1981-05       Impact factor: 3.199

3.  Sulfation of lithocholate as a possible modifier of chenodeoxycholic acid-induced elevations of serum transaminase in patients with gallstones.

Authors:  J W Marks; S O Sue; B J Pearlman; G G Bonorris; P Varady; J M Lachin; L J Schoenfield
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

Review 4.  Chenodeoxycholic acid: a review of its pharmacological properties and therapeutic use.

Authors:  J H Iser; A Sali
Journal:  Drugs       Date:  1981-02       Impact factor: 9.546

Review 5.  Key discoveries in bile acid chemistry and biology and their clinical applications: history of the last eight decades.

Authors:  Alan F Hofmann; Lee R Hagey
Journal:  J Lipid Res       Date:  2014-05-17       Impact factor: 5.922

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.